title: Benfluorex: the last chapter of drug-induced valvular heart disease?
authors.forename: Steven
authors.initials: S
authors.lastname: Droogmans
authors.forename: Bernard
authors.initials: B
authors.lastname: Cosyns
authors.forename: Guy
authors.initials: G
authors.lastname: Van Camp
mesh_terms: D000889:Anti-Arrhythmia Agents / Q000009:adverse effects; D000959:Antihypertensive Agents / Q000009:adverse effects; D001067:Appetite Depressants / Q000009:adverse effects*; D005060:Europe / Q000453:epidemiology; D005277:Fenfluramine / Q000009:adverse effects / Q000031:analogs & derivatives*; D005602:France / Q000453:epidemiology; D016316:Guanfacine / Q000009:adverse effects; D006349:Heart Valve Diseases / Q000139:chemically induced* / Q000453:epidemiology; D006801:Humans; D006976:Hypertension, Pulmonary / Q000139:chemically induced / Q000453:epidemiology; D015337:Multicenter Studies as Topic; D011802:Quinidine / Q000009:adverse effects; D014481:United States / Q000453:epidemiology
chemical_list: D000889:Anti-Arrhythmia Agents; D000959:Antihypertensive Agents; D001067:Appetite Depressants; D005277:Fenfluramine; D016316:Guanfacine; C001584:benfluorex; D011802:Quinidine